Assessing Cognitive fUnction and MEasuring the Cerebral circulatioN on HaemoDialysis "ACUMEN-HD"
Not yet recruiting
Phase N/A Results N/ASummary of Purpose
Stroke disease and cognitive impairment are common in patients established on haemodialysis (HD) for end-stage renal disease (ESRD). Further, initiation of HD appears to transiently increase the risk of stroke. The mechanism by which this occurs is not known. Using ultrasound, patient questionnaires and brain MRI our study will observe changes in cognition and cerebral blood flow whilst receiving HD compared to...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 18 March 2015.
1 Mar 2015 | 26 Feb 2015 | 1 Aug 2016 | 1 Aug 2017 | 1 Mar 2015 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Observation: Cohort
- Perspective: Prospective
- Sampling: Probability Sample
Contacts
- Mark D Findlay, MBChB
- Patrick B Mark, MBChB PhD
patrick.mark@glasgow.ac.uk 0141 3308218
Recruitment
- Enrollment: 97
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
Principal Investigator
- Mark D Findlay, MBChB
University of Glasgow